Cullinan Therapeutics’ $280 Million Private Placement

Leila Ahmed
Tagged:

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Foresite Capital in the transaction.Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company, announced…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now